De-Regulation of JNK and JAK/STAT Signaling in ESCRT-II Mutant Tissues Cooperatively Contributes to Neoplastic Tumorigenesis

Woodfield, Sarah E.; Graves, Hillary K.; Hernandez, Jacob A.; Bergmann, Andreas
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
Multiple genes involved in endocytosis and endosomal protein trafficking in Drosophila have been shown to function as neoplastic tumor suppressor genes (nTSGs), including Endosomal Sorting Complex Required for Transport-II (ESCRT-II) components vacuolar protein sorting 22 (vps22), vps25, and vps36. However, most studies of endocytic nTSGs have been done in mosaic tissues containing both mutant and non-mutant populations of cells, and interactions among mutant and non-mutant cells greatly influence the final phenotype. Thus, the true autonomous phenotype of tissues mutant for endocytic nTSGs remains unclear. Here, we show that tissues predominantly mutant for ESCRT-II components display characteristics of neoplastic transformation and then undergo apoptosis. These neoplastic tissues show upregulation of c-Jun N-terminal Kinase (JNK), Notch, and Janus Kinase (JAK)/Signal Transducer and Activator of Transcription (STAT) signaling. Significantly, while inhibition of JNK signaling in mutant tissues partially inhibits proliferation, inhibition of JAK/STAT signaling rescues other aspects of the neoplastic phenotype. This is the first rigorous study of tissues predominantly mutant for endocytic nTSGs and provides clear evidence for cooperation among de-regulated signaling pathways leading to tumorigenesis.


Related Articles

  • JNK3 Maintains Expression of the Insulin Receptor Substrate 2 (IRS2) in Insulin-Secreting Cells: Functional Consequences for Insulin Signaling. Abdelli, Saida; Bonny, Christophe // PLoS ONE;May2012, Vol. 7 Issue 5, p1 

    We have recently shown that silencing of the brain/islet specific c-Jun N-terminal Kinase3 (JNK3) isoform enhances both basal and cytokine-induced beta-cell apoptosis, whereas silencing of JNK1 or JNK2 has opposite effects. While it is known that JNK1 or JNK2 may promote apoptosis by inhibiting...

  • Inhibition of c-Jun N-terminal Kinase Ameliorates Early Brain Injury After Subarachnoid Hemorrhage Through Inhibition of a Nur77 Dependent Apoptosis Pathway. Dai, Yuxiang; Zhang, Wen; Zhou, Xiaoming; Shi, Jixin // Neurochemical Research;Aug2014, Vol. 39 Issue 8, p1603 

    Nur77 is a potent pro-apoptotic member of the orphan nuclear receptor superfamily. Our previous study revealed Nur77-mediated apoptotic also involved in early brain injury (EBI) after experimental subarachnoid hemorrhage (SAH). Previous researches show that c-Jun N-terminal kinase (JNK)...

  • Endoplasmic Reticulum Stress-Induced JNK Activation Is a Critical Event Leading to Mitochondria-Mediated Cell Death Caused by β-Lapachone Treatment. Lee, Hyemi; Park, Moon-Taek; Choi, Bo-Hwa; Oh, Eun-Taex; Song, Min-Jeong; Lee, Jeonghun; Kim, Chulhee; Lim, Byung Uk; Park, Heon Joo // PLoS ONE;2011, Vol. 6 Issue 6, p1 

    Background: b-lapachone (b-lap) is a bioreductive agent that is activated by the two-electron reductase NAD(P)H quinone oxidoreductase 1 (NQO1). Although b-lap has been reported to induce apoptosis in various cancer types in an NQO1- dependent manner, the signaling pathways by which b-lap causes...

  • Hippo and rassf1a Pathways: A Growing Affair. Fausti, Francesca; Agostino, Silvia Di; Sacconi, Andrea; Strano, Sabrina; Blandino, Giovanni // Molecular Biology International;2012, p1 

    First discovered in Drosophila, the Hippo pathway regulates the size and shape of organ development. Its discovery and study have helped to address longstanding questions in developmental biology. Central to this pathway is a kinase cascade leading from the tumor suppressor Hippo (Mst1 and Mst2...

  • Critical roles of non-histone protein lysine methylation in human tumorigenesis. Hamamoto, Ryuji; Saloura, Vassiliki; Nakamura, Yusuke // Nature Reviews Cancer;Feb2015, Vol. 15 Issue 2, p110 

    Several protein lysine methyltransferases and demethylases have been identified to have critical roles in histone modification. A large body of evidence has indicated that their dysregulation is involved in the development and progression of various diseases, including cancer, and these enzymes...

  • Bid-ding for mercy: twisted killer in action. Egle, A; Asslaber, D; Villunger, A; Pinon-Hofbauer, J // Cell Death & Differentiation;Jul2013, Vol. 20 Issue 7, p847 

    The authors discuss a study by S. Biswas et al on the role of the pro-apoptotic BH3-only protein Bid in tumorigenesis. They argue on the findings that Bid does not seem to be a protection from cell death in the stem cell compartment. They note the earlier controversy on the role of Bid in...

  • RBB, a novel transcription repressor, represses the transcription of HDM2 oncogene. Xuan, C; Wang, Q; Han, X; Duan, Y; Li, L; Shi, L; Wang, Y; Shan, L; Yao, Z; Shang, Y // Oncogene;8/8/2013, Vol. 32 Issue 32, p3711 

    The p53 tumor suppressor is important in many aspects of cell biology. Tight regulation of p53 is thus imperative for maintaining cell homeostasis and preventing tumorigenesis. The stabilization and activity of p53 is primarily regulated by MDM2, which is encoded for by HDM2. However, how the...

  • Chemical suppression of an oncogenic splicing variant of AIMP2 induces tumour regression. LEE, Hee Sook; KIM, Dae Gyu; Young Sun OH; Nam Hoon KWON; Jin Young LEE; Doyeun KIM; Song-Hwa PARK; Jong-Hwan SONG; Sunkyung LEE; Jung Min HAN; Bum-Joon PARK; Jongkook LEE; Sunghoon KIM // Biochemical Journal;9/15/2013, Vol. 454 Issue 3, preceding p411 

    AIMP2 (aminoacyl-tRNA synthetase-interacting multifunctional protein 2) is a potent tumour suppressor that induces apoptosis in response to various oncogenic signals. AIMP2-DX2, an exon2- deleted splicing variant of AIMP2, is up-regulated in lung cancer and competitively suppresses the...

  • Induction of p53-independent apoptosis by ectopic expression of HOXA5 in human liposarcomas. Lee, Dhong Hyun; Forscher, Charles; Vizio, Dolores Di; Koeffler, H. Phillip // Scientific Reports;7/31/2015, p12580 

    Dedifferentiated liposarcoma (DDLPS) is a highly malignant subtype of human liposarcoma (LPS), whose genomic profile is characterized by chromosomal amplification at 12q13-q22. miR-26a-2 is one of the most frequently amplified genes in the region, and inhibition of its downstream target genes...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics